Tolvaptan Therapy for Kidney Cyst Growth
This treatment is often recommended for adults who are at risk of rapidly progressive ADPKD. The medication is taken orally to slow the growth of cysts in the kidney and the drop in your kidney’s efficiency. The drug, called Tolvaptan, was approved by the Food and Drug Administration (FDA) [6] in 2018 and is sold as Samsca and Jynarque.
Tolvaptan can have potentially serious side effects, such as liver injury. It can also interfere with the activity of other drugs in the body and cause problems. To avoid or manage potential complications, it is best to take this drug under the supervision of a kidney specialist. They will prescribe the right dosage and monitor you for side effects.